OpenAlex
PricingAboutJobs
Log inGet started
Work

Cyclin dependent kinase (CDK) inhibitors as anticancer drugs

HTML

Year: 2015
Type: review
Source: Bioorganic & Medicinal Chemistry Letters
DOI: 10.1016/j.bmcl.2015.05.100
Authors: Concepción Sánchez-Martínez, Lawrence M. Gelbert, María José Lallena, Alfonso de Dios
Institutions: Eli Lilly (Spain), Indiana University Indianapolis, Indiana University School of Medicine, Eli Lilly (United States)
Language: English

Topic: Advanced Breast Cancer Therapies
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: cyclin-dependent kinase inhibitors, CDK4 inhibitors, CDK6 inhibitors, anticancer drug targets, cell cycle regulation, structure-activity relationship, clinical drug candidates, tumor cell proliferation
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2189238890
FWCI: 2.816
Cites: 70
Cited by: 255
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms